02626nas a2200265   4500000000100000008004100001260001200042653001300054653003500067653001600102653003500118653003100153100002200184700001100206700001600217700001600233700001500249700001300264245017600277856008700453300000900540490000700549520179000556022001402346       2023                            d  c12/202310aHIV/aids10afemale genital schistosomiasis10aIntegration10aSexual and reproductive health10aUrogenital schistosomiasis1 aUmbelino-Walker I1 aWong F1 aCassolato M1 aPantelias A1 aJacobson J1 aKalume C00aIntegration of female genital schistosomiasis into HIV/sexual and reproductive health and rights and neglected tropical diseases programmes and services: a scoping review.  uhttps://www.tandfonline.com/doi/epdf/10.1080/26410397.2023.2262882?needAccess=true  a1-170 v313 a<p>Female genital schistosomiasis (FGS) affects approximately 56 million women and girls across sub-Saharan Africa and is associated with up to a threefold increased prevalence of HIV. Integrating FGS with HIV programmes as part of comprehensive sexual and reproductive health (SRH) services may be one of the most significant missed opportunities for preventing HIV incidence among girls and women. A search of studies published until October 2021 via Scopus and ProQuest was conducted using PRISMA guidelines to assess how FGS can be integrated into HIV/SRH and neglected tropical diseases (NTDs) programmes and services. Data extraction included studies that integrated interventions and described the opportunities and challenges. A total of 334 studies were identified, with 22 eligible for analysis and summarised conducting a descriptive numerical analysis and qualitative review. We adapted a framework for integrated implementation of FGS, HIV, and HPV/cervical cancer to thematically organise the results, classifying them into five themes: awareness and community engagement, diagnosis, treatment, burden assessment, and economic evaluation. Most activities pertained to awareness and community engagement ( = 9), diagnosis ( = 9) and were primarily connected to HIV/AIDS ( = 8) and school-based services and programming ( = 8). The studies mainly described the opportunities and challenges for integration, rather than presenting results from implemented integration interventions, highlighting an evidence gap on FGS integration into HIV/SRH and NTD programmes. Investments are needed to realise the potential of FGS integration to address the burden of this neglected disease and improve HIV and SRH outcomes for millions of women and girls at risk.</p>
  a2641-0397